4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-23-117365
EVP, Head of North America sold 9,150 shares at an average $28.45 ($260,287)
- EVP, Head of North America acquired 9,150 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lee Jennifer Kayden · EVP, Head of North America
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,712 | $6.80 | $38,842 | 7,359 | D |
| 2023-11-08 | Sale : show line 2 in the form 10b5-1 | −3,479 | $28.64 | $99,649 | 3,880 | D |
| 2023-11-08 | Sale : show line 3 in the form 10b5-1 | −2,233 | $29.31 | $65,456 | 1,647 | D |
| 2023-11-09 | Exercise or conversion : show line 4 in the form 10b5-1 | +3,438 | $6.80 | $23,378 | 5,085 | D |
| 2023-11-09 | Sale : show line 5 in the form 10b5-1 | −1,719 | $27.37 | $47,051 | 3,366 | D |
| 2023-11-09 | Sale : show line 6 in the form 10b5-1 | −1,719 | $28.00 | $48,132 | 1,647 | D |
| Open-market sales · 9,150 sh · avg $28.45 · $260,287 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-11-08 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −5,712 | 61,880 | D |
| 2023-11-09 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) | −3,438 | 58,442 | D |
Loading xslF345X05/tm2330582-1_4seq1.xml…